[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Cardiovascular Drug Market Report 2017

October 2017 | 100 pages | ID: UC42F5D728DEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Cardiovascular Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Cardiovascular Drug in these regions, from 2012 to 2022 (forecast).
United States Cardiovascular Drug market competition by top manufacturers/players, with Cardiovascular Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Merck
  • Novartis
  • Takeda Pharmaceutical
  • Astellas Pharma Inc
  • Boehringer Ingelheim GmbH
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Heparin
  • Coumadin
  • Zebeta
  • Lopressor
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Medical Center
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Cardiovascular Drug Market Report 2017

1 CARDIOVASCULAR DRUG OVERVIEW

1.1 Product Overview and Scope of Cardiovascular Drug
1.2 Classification of Cardiovascular Drug by Product Category
  1.2.1 United States Cardiovascular Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cardiovascular Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Heparin
  1.2.4 Coumadin
  1.2.5 Zebeta
  1.2.6 Lopressor
  1.2.7 Others
1.3 United States Cardiovascular Drug Market by Application/End Users
  1.3.1 United States Cardiovascular Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Medical Center
  1.3.5 Others
1.4 United States Cardiovascular Drug Market by Region
  1.4.1 United States Cardiovascular Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cardiovascular Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Cardiovascular Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cardiovascular Drug Status and Prospect (2012-2022)
  1.4.5 New England Cardiovascular Drug Status and Prospect (2012-2022)
  1.4.6 The South Cardiovascular Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Cardiovascular Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cardiovascular Drug (2012-2022)
  1.5.1 United States Cardiovascular Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Cardiovascular Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES CARDIOVASCULAR DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cardiovascular Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cardiovascular Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cardiovascular Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Cardiovascular Drug Market Competitive Situation and Trends
  2.4.1 United States Cardiovascular Drug Market Concentration Rate
  2.4.2 United States Cardiovascular Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cardiovascular Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CARDIOVASCULAR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cardiovascular Drug Sales and Market Share by Region (2012-2017)
3.2 United States Cardiovascular Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Cardiovascular Drug Price by Region (2012-2017)

4 UNITED STATES CARDIOVASCULAR DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cardiovascular Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cardiovascular Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Cardiovascular Drug Price by Type (2012-2017)
4.4 United States Cardiovascular Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CARDIOVASCULAR DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cardiovascular Drug Sales and Market Share by Application (2012-2017)
5.2 United States Cardiovascular Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CARDIOVASCULAR DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cardiovascular Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Cardiovascular Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.2 Cardiovascular Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.2 Cardiovascular Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis
  6.5.2 Cardiovascular Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceutical
  6.6.2 Cardiovascular Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceutical Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Astellas Pharma Inc
  6.7.2 Cardiovascular Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Astellas Pharma Inc Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Boehringer Ingelheim GmbH
  6.8.2 Cardiovascular Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Boehringer Ingelheim GmbH Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 CARDIOVASCULAR DRUG MANUFACTURING COST ANALYSIS

7.1 Cardiovascular Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cardiovascular Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cardiovascular Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cardiovascular Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CARDIOVASCULAR DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cardiovascular Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cardiovascular Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Cardiovascular Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Cardiovascular Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Cardiovascular Drug
Figure United States Cardiovascular Drug Market Size (Units) by Type (2012-2022)
Figure United States Cardiovascular Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Heparin Product Picture
Figure Coumadin Product Picture
Figure Zebeta Product Picture
Figure Lopressor Product Picture
Figure Others Product Picture
Figure United States Cardiovascular Drug Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Cardiovascular Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Cardiovascular Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Cardiovascular Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cardiovascular Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cardiovascular Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cardiovascular Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cardiovascular Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cardiovascular Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiovascular Drug Sales (Units) and Growth Rate (2012-2022)
Figure United States Cardiovascular Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiovascular Drug Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Cardiovascular Drug Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Cardiovascular Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiovascular Drug Sales Share by Players/Suppliers
Figure 2017 United States Cardiovascular Drug Sales Share by Players/Suppliers
Figure United States Cardiovascular Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cardiovascular Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cardiovascular Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiovascular Drug Revenue Share by Players/Suppliers
Figure 2017 United States Cardiovascular Drug Revenue Share by Players/Suppliers
Table United States Market Cardiovascular Drug Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cardiovascular Drug Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cardiovascular Drug Market Share of Top 3 Players/Suppliers
Figure United States Cardiovascular Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cardiovascular Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cardiovascular Drug Product Category
Table United States Cardiovascular Drug Sales (Units) by Region (2012-2017)
Table United States Cardiovascular Drug Sales Share by Region (2012-2017)
Figure United States Cardiovascular Drug Sales Share by Region (2012-2017)
Figure United States Cardiovascular Drug Sales Market Share by Region in 2016
Table United States Cardiovascular Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cardiovascular Drug Revenue Share by Region (2012-2017)
Figure United States Cardiovascular Drug Revenue Market Share by Region (2012-2017)
Figure United States Cardiovascular Drug Revenue Market Share by Region in 2016
Table United States Cardiovascular Drug Price (K USD/Unit) by Region (2012-2017)
Table United States Cardiovascular Drug Sales (Units) by Type (2012-2017)
Table United States Cardiovascular Drug Sales Share by Type (2012-2017)
Figure United States Cardiovascular Drug Sales Share by Type (2012-2017)
Figure United States Cardiovascular Drug Sales Market Share by Type in 2016
Table United States Cardiovascular Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cardiovascular Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cardiovascular Drug by Type (2012-2017)
Figure Revenue Market Share of Cardiovascular Drug by Type in 2016
Table United States Cardiovascular Drug Price (K USD/Unit) by Types (2012-2017)
Figure United States Cardiovascular Drug Sales Growth Rate by Type (2012-2017)
Table United States Cardiovascular Drug Sales (Units) by Application (2012-2017)
Table United States Cardiovascular Drug Sales Market Share by Application (2012-2017)
Figure United States Cardiovascular Drug Sales Market Share by Application (2012-2017)
Figure United States Cardiovascular Drug Sales Market Share by Application in 2016
Table United States Cardiovascular Drug Sales Growth Rate by Application (2012-2017)
Figure United States Cardiovascular Drug Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure Pfizer Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure Sanofi Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure Merck Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure Merck Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure Novartis Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure Novartis Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure Astellas Pharma Inc Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Inc Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Cardiovascular Drug Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Cardiovascular Drug Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Cardiovascular Drug Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim GmbH Cardiovascular Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cardiovascular Drug
Figure Manufacturing Process Analysis of Cardiovascular Drug
Figure Cardiovascular Drug Industrial Chain Analysis
Table Raw Materials Sources of Cardiovascular Drug Major Players/Suppliers in 2016
Table Major Buyers of Cardiovascular Drug
Table Distributors/Traders List
Figure United States Cardiovascular Drug Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Cardiovascular Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cardiovascular Drug Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Cardiovascular Drug Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Cardiovascular Drug Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Cardiovascular Drug Sales Volume (Units) Forecast by Type in 2022
Table United States Cardiovascular Drug Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Cardiovascular Drug Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Cardiovascular Drug Sales Volume (Units) Forecast by Application in 2022
Table United States Cardiovascular Drug Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Cardiovascular Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiovascular Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiovascular Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories